Eric Barton Suhler MD MPH
Retinal Disease, Uveitis
Professor, Ophthalmology and Public Health, Oregon Health and Science University, and Chief of Ophthalmology, VA Portland Health Care System
Join to View Full Profile
3375 Sw Terwilliger BlvdPortland, OR 97239
Phone+1 503-494-5023
Fax+1 503-494-6875
Dr. Suhler is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Oregon Health & Science UniversityMPH, Epidemiology and Biostatistics, Outstanding Thesis, 1999 - 2007
Oregon Health & Science University (OHSU Health)Residency, Ophthalmology, 1996 - 2000
University of HawaiiInternship, Internal Medicine, 1995 - 1996
University of Texas Southwestern Medical SchoolClass of 1995
Certifications & Licensure
OR State Medical License 2002 - 2025
MD State Medical License 2000 - 2003
HI State Medical License 1995 - 1996
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- A Clinical Trial of Infliximab for Uveitis Start of enrollment: 2001 Aug 01
- Rituximab in the Treatment of Scleritis and Non-Infectious Orbital Inflammation Start of enrollment: 2007 Jan 01
- Adalimumab (Humira) in the Treatment of Refractory Non-infectious Uveitis Start of enrollment: 2008 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- Electroretinography of disease activity and treatment response in birdshot chorioretinopathy.Christopher R Rosenberg, Elizabeth White, Aseel Alsamarraie, Sandip Suresh, Wayne Tschetter
Eye. 2025-03-28 - SUCCESSFUL TREATMENT OF CANCER-ASSOCIATED RETINOPATHY WITH INTRAVITREAL DEXAMETHASONE IMPLANT FOLLOWED BY A 0.18-MG FLUOCINOLONE IMPLANT WITHOUT SYSTEMIC IMMUNOSUPPRES...Lingling Huang, Paul Yang, Christina Flaxel, Eric Suhler, Phoebe Lin
Retinal Cases & Brief Reports. 2025-03-01 - Incidence and Outcome of Cataract in Eyes with Scleritis and Episcleritis.Michelle J Sun, Bernard A Rosner, Craig W Newcomb, Kurt A Dreger, Pichaporn Artornsombudh
Ocular Immunology and Inflammation. 2025-02-12
Press Mentions
NEW PRODUCT APPLICATIONS: Yutiq Implant for Chronic Noninfectious Posterior-Segment UveitisApril 1st, 2019
Professional Memberships
- Fellow
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
